4C Capital

IGeneX, Inc. is a specialty immunology laboratory and research facility based in Palo Alto, California, founded in 1991. The company focuses on developing laboratory assays for Lyme disease and other tick-borne diseases, providing advanced PCR testing to detect pathogens associated with these conditions. IGeneX serves private practice physicians, hospitals, and clinical reference laboratories across the United States and Canada. In addition to diagnostic testing, the laboratory functions as a pilot site for diagnostic manufacturers, facilitating the introduction of new assays. Through its comprehensive research and testing services, IGeneX aims to assist healthcare providers in achieving timely diagnoses and implementing appropriate treatment paths for patients affected by tick-borne diseases.